Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Evolution And NotOlof Solin

List of bibliographic references

Number of relevant bibliographic references: 128.
Ident.Authors (with country if any)Title
000140 Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France]Long-Term Outcomes of Surgical Therapies for Parkinson's Disease
000323 Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Bichun Ouyang [États-Unis]Visual Plus Nonvisual Hallucinations in Parkinson's Disease: Development and Evolution over 10 Years
000430 Ellis Chan [France] ; Perrine Charles [France] ; Pascale Ribai [France] ; Cyril Goizet [France] ; Cecilia Marelli [France] ; Carlo-Maria Vincitorio [France] ; Alice Le Bayon [France] ; Lucie Guyant-Marechal [France] ; Nadia Vandenberghe [France] ; Mathieu Anheim [France] ; David Devos [France] ; Leorah Freeman [France] ; Isabelle Le Ber [France] ; Karine N'Guyen [France] ; Maya Tchikviladze [France] ; Pierre Labauge [France] ; Didier Hannequin [France] ; Alexis Brice [France] ; Alexandra Durr [France] ; Sophie Tezenas Du Montcel [France]Quantitative Assessment of the Evolution of Cerebellar Signs in Spinocerebellar Ataxias
000608 Melissa J. Armstrong [Canada] ; Binit B. Shah [Canada] ; Robert Chen [Canada] ; Michael J. Angel [Canada] ; Anthony E. Lang [Canada]Expanding the Phenomenology of Benign Hereditary Chorea: Evolution from Chorea to Myoclonus and Dystonia
000A34 Amaryllis Van Craenenbroeck [Belgique] ; Marilien Gebruers [Belgique] ; Jean-Jacques Martin [Belgique] ; Patrick Cras [Belgique]Hallervorden-Spatz Disease: Historical Case Presentation in the Spotlight of Nosological Evolution
000D51 Samyra H. J. Keus [Pays-Bas] ; Marten Munneke [Pays-Bas] ; Maarten J. Nijkrake [Pays-Bas] ; Gert Kwakkel [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas]Physical Therapy in Parkinson's Disease : Evolution and Future Challenges
000E87 Aglaia Vignoli [Italie] ; Francesca La Briola [Italie] ; Maria Paola Canevini [Italie]Evolution of Stereotypies in Adolescents and Women with Rett Syndrome
001064 Lisa M. Shulman [États-Unis] ; Ann L. Gruber-Baldini [États-Unis] ; Karen E. Anderson [États-Unis] ; Christopher G. Vaughan [États-Unis] ; Stephen G. Reich [États-Unis] ; Paul S. Fishman [États-Unis] ; William J. Weiner [États-Unis]The Evolution of Disability in Parkinson Disease
001B04 Karen Stergaard [Danemark] ; Niels Aa. Sunde [Danemark]Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus
002285 Jan Herzog [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [Allemagne] ; Florian Kopper [Allemagne] ; Monika Potter [Allemagne] ; Delia Lorenz [Allemagne] ; Meike Steinbach [Allemagne] ; Stefan Klebe [Allemagne] ; Wolfgang Hamel [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Weinert [Allemagne] ; Dieter Müller [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Günther Deuschl [Allemagne]Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease
002297 John M. Walshe [Royaume-Uni]The story of penicillamine: A difficult birth
002300 Lesley Swinn [Royaume-Uni] ; Anette Schrag [Royaume-Uni] ; Ramchandran Viswanathan [Royaume-Uni] ; Bastiaan R. Bloem [Royaume-Uni, Pays-Bas] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Sweating dysfunction in Parkinson's disease
002342 Padraig O'Suilleabhain [États-Unis] ; Cole Giller [États-Unis]Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs
002384 Marcelo Merello [Argentine] ; Jorge Balej [Argentine] ; Ramon Leiguarda [Argentine]Pallidotomy in Parkinson's disease improves single-joint, repetitive, ballistic movements, but fails to modify multijoint, repetitive, gestural movements
002396 Galit Kleiner-Fisman [Canada] ; Sandra E. Black [Canada] ; Anthony E. Lang [Canada]Neurodegenerative disease and the evolution of art: The effects of presumed corticobasal degeneration in a professional artist
002403 Josep Valls-Sole [Espagne] ; Jordi MonteroMovement disorders in patients with peripheral facial palsy
002408 Walter Pirker [Autriche] ; Iris Holler [Autriche] ; Willibald Gerschlager [Autriche] ; Susanne Asenbaum [Autriche] ; Georg Zettinig [Autriche] ; Thomas Brücke [Autriche]Measuring the rate of progression of Parkinson's disease over a 5-year period with β-CIT SPECT
002436 Paul K. Morrish [Royaume-Uni]How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease?
002439 Anette Schrag [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Jennifer Davis [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Niall Quinn [Royaume-Uni]Health-related quality of life in patients with progressive supranuclear palsy
002446 Marwan I. Hariz [Suède, Royaume-Uni]From functional neurosurgery to "interventional" neurology: Survey of publications on thalamotomy, pallidotomy, and deep brain stimulation for Parkinson's disease from 1966 to 2001
002475 Craig E. Hou [États-Unis] ; Bradley L. Schlaggar [États-Unis] ; Brad A. Racette [États-Unis]Dystonia in a patient with ring chromosome 21
002485 Gun-Marie Hariz [Suède] ; Margareta Lindberg [Suède] ; Marwan I. Hariz [Suède] ; A. Tommy Bergenheim [Suède]Does the ADL Part of the Unified Parkinson's Disease Rating Scale Measure ADL? An evaluation in patients after pallidotomy and thalamic deep brain stimulation
002494 Jonathan M. Schott [Royaume-Uni] ; Jessica E. Simon [Royaume-Uni] ; Nick C. Fox [Royaume-Uni] ; Andrew P. King [Royaume-Uni] ; M. Nadeem Khan [Royaume-Uni] ; Lisa Cipolotti [Royaume-Uni] ; Dominic C. Paviour [Royaume-Uni] ; John M. Stevens [Royaume-Uni] ; Martin N. Rossor [Royaume-Uni]Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI
002495 Daphna Joel [Israël] ; Liat Ayalon [Israël] ; Ricardo Tarrasch [Israël] ; Ina Weinei [Israël]Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: A potential novel treatment in a rat model of Huntington's disease
002504 Walter Pirker [Autriche]Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?
002507 Elan D. Louis [États-Unis] ; Eva C. Jurewicz [États-Unis] ; Dryden Watner [États-Unis]Community-based data on associations of disease duration and age with severity of essential tremor: Implications for disease pathophysiology
002510 Montse Alegret [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne] ; Pere Vendrell [Espagne] ; Carme Junque [Espagne] ; José Martinez [Espagne] ; Jordi Rumia [Espagne]Cognitive effects of unilateral posteroventral pallidotomy: A 4-year follow-up study
002559 Virgilio Gerald H. Evidente [États-Unis, Philippines] ; Katrina Gwinn-Hardy [États-Unis] ; John Hardy [États-Unis] ; Dena Hernandez [États-Unis] ; Andrew Singleton [États-Unis]X-linked dystonia ("Lubag") presenting predominantly with parkinsonism: A more benign phenotype?
002562 William G. Ondo [États-Unis] ; LING LING CHAN [États-Unis] ; Joel K. Levy [États-Unis]Vascular parkinsonism : Clinical correlates predicting motor improvement after lumbar puncture
002571 Pierre Pollak [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Elena Moro [France] ; Alexandre Mendes [France] ; Stephan Chabardes [France] ; Adnan Koudsie [France] ; Alim-Louis Benabid [France]Treatment results: Parkinson's disease
002589 Daniel Tarsy [États-Unis] ; Gerald Indorf [États-Unis]Tardive tremor due to metoclopramide
002618 Charles H. Adler [États-Unis] ; Stewart A. Factor [États-Unis] ; Mitchell Brin [États-Unis] ; Kapil D. Sethi [États-Unis]Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia
002623 Laurent Vercueil [France] ; Paul Krack [France] ; Pierre Pollak [France]Results of deep brain stimulation for dystonia: A critical reappraisal
002633 Alastair Gray [Royaume-Uni] ; Lain Mcnamara [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Joanna Wilson [Royaume-Uni] ; Richard Scott [Royaume-Uni]Quality of life outcomes following surgical treatment of Parkinson's disease
002638 Walter Pirker [Autriche] ; Schiva Djamshidian [Autriche] ; Susanne Asenbaum [Autriche] ; Willibald Gerschlager [Autriche] ; Gotthard Tribl [Autriche] ; Martha Hoffmann [Autriche] ; Thomas Brücke [Autriche]Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β-CIT SPECT study
002644 Ann L. Smiley-Oyen [États-Unis] ; Charles J. Worringham [Australie] ; Carol L. Cross [États-Unis]Practice effects in three-dimensional sequential rapid aiming in Parkinson's disease
002649 Jasmine M. Henderson [Australie] ; Malcolm Pell [Australie] ; Dudley J. O'Sullivan [Australie] ; Elizabeth A. Mccusker [Australie] ; Victor S. C. Fung [Australie] ; Philippa Hedges [Australie] ; Glenda M. Halliday [Australie]Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease
002678 J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas]Neurosurgical treatment modalities in Parkinson's disease
002686 Craig D. Mccoll [Australie] ; Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease
002693 Gilberto Levy [États-Unis] ; Diane M. Jacobs [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Brenda Alfaro [États-Unis] ; Helen Mejia [États-Unis] ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis]Memory and executive function impairment predict dementia in Parkinson's disease
002701 Franck Durif [France] ; Jean-Jacques Lemaire [France] ; Bérengère Debilly [France] ; Gérard Dordain [France]Long-term follow-up of globus pallidus chronic stimulation in advanced Parkinson's Disease
002702 G-Y. R. Hsiung [Canada] ; S. K. Das [Canada] ; R. Ranawaya [Canada] ; A.-L. Lafontaine [Canada] ; O. Suchowersky [Canada]Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period
002703 Juliane Winkelmann [Allemagne] ; Anette Stautner [Allemagne] ; Walter Samtleben [Allemagne] ; Claudia Trenkwalder [Allemagne]Long-term course of Restless legs syndrome in dialysis patients after kidney transplantation
002712 Patrick F. Chinnery [Royaume-Uni] ; Paul J. Reading [Royaume-Uni] ; Emma L. Mccarthy [Royaume-Uni] ; Ann Curtis [Royaume-Uni] ; David J. Burn [Royaume-Uni]Late-onset axial jerky dystonia due to the DYT1 deletion
002715 André Parent [Canada]Jules Bernard Luys and the subthalamic nucleus
002730 Pierre Burbaud [France] ; Alain Rougier [France] ; Xavier Ferrer [France] ; Dominique Guehl [France] ; E. Cuny [France] ; Pierre Arne [France] ; Ch. Gross [France] ; B. Bioulac [France]Improvement of severe trunk spasms by bilateral high-frequency stimulation of the motor thalamus in a patient with chorea-acanthocytosis
002753 Michael R. Pranzatelli [États-Unis] ; Elizabeth D. Tate [États-Unis] ; Marcel Kinshourne [États-Unis] ; Verne S. Jr Caviness [États-Unis] ; Bibhuti Mishra [États-Unis]Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG
002779 Willibald Gerschlager [Royaume-Uni] ; Peter Brown [Royaume-Uni]Effect of treatment with intravenous immunoglobulin on quality of life in patients with stiff-person syndrome
002796 Gilberto Levy [États-Unis] ; Ming-Xin Tang [États-Unis] ; Lucien J. Cote [États-Unis] ; Elan D. Louis [États-Unis] ; Brenda Alfaro [États-Unis] ; Helen Mejia [États-Unis] ; Yaakov Stern [États-Unis] ; Karen Marder [États-Unis]Do risk factors for Alzheimer's Disease predict dementia in Parkinson's disease? An exploratory study
002825 Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra [États-Unis] ; Robert A. Hauser [États-Unis]Clozapine withdrawal symptoms in a Parkinson's disease patient
002838 Jakob Christensen [Danemark] ; Erik Dupont [Danemark] ; Karen Stergaard [Danemark]Cabergoline plasma concentration is increased during concomitant treatment with itraconazole
002842 Dirk Dressler [Royaume-Uni] ; Hans Bigalke [Allemagne]Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy
002866 Lisa M. Shulman [États-Unis] ; X. Wen [États-Unis] ; William J. Weiner [États-Unis] ; Dinorah Bateman [États-Unis] ; Alireza Minagar [États-Unis] ; Robert Duncan [États-Unis] ; Janet Konefal [États-Unis]Acupuncture therapy for the symptoms of Parkinson's Disease
002867 Marcelo Merello [Argentine] ; Maria I. Nouzeilles [Argentine] ; Gabriel Piran Arce [Argentine] ; Ramon Leiguarda [Argentine]Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis
002888 Steven J. Frucht [États-Unis] ; Stanley Fahn [États-Unis] ; Paul E. Greene [États-Unis] ; Christopher O'Brien [États-Unis] ; Michael Gelb [États-Unis] ; Daniel D. Truong [États-Unis] ; John Welsh [États-Unis] ; Stewart Factor [États-Unis] ; Blair Ford [États-Unis]The natural history of embouchure dystonia
002894 William Ondo [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Michael Almaguer [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard K. Simpson [États-Unis]Thalamic deep brain stimulation: Effects on the nontarget limbs
002917 Joohi Shahed [États-Unis] ; Joseph Jankovic [États-Unis]Re-emergence of Childhood stuttering in Parkinson's disease : A hypothesis
002927 Anette Schrag [Royaume-Uni] ; Michael Trimble [Royaume-Uni]Poetic talent unmasked by treatment of Parkinson's disease
002933 J. Eric Ahlskog [États-Unis] ; Hiroshi Nishino [Japon] ; V. G. H. Evidente [États-Unis] ; John W. Tulloch [États-Unis] ; Glenn S. Forbes [États-Unis] ; John N. Caviness [États-Unis] ; Katrina A. Gwinn-Hardy [États-Unis]Persistent chorea triggered by hyperglycemic crisis in diabetics
002939 Jasmine M. Henderson [Australie] ; WEI PING GAI [Australie] ; Mariese A. Hely [Australie] ; Wayne G. J. Reid [Australie] ; Grant L. Walker [Australie] ; Glenda M. Halliday [Australie]Parkinson's disease with late Pick's dementia
002943 Nicholas Scarmato [États-Unis] ; David Eidelberg [États-Unis] ; Steven J. Frucht [États-Unis]Oculogyric-like crises in a 92-year-old woman with vascular parkinsonism
002944 R. E. Yee [États-Unis] ; I. Irwin [États-Unis] ; C. Milonas [États-Unis] ; D. B. Stout [États-Unis] ; S-C. Huang [États-Unis] ; K. Shoghi-Jadid [États-Unis] ; N. Satyamurthy [États-Unis] ; L. E. Delanney [États-Unis] ; D. M. Togasaki [États-Unis] ; K. F. Farahani [États-Unis] ; K. Delfani [États-Unis] ; A. M. Janson [États-Unis] ; M. E. Phelps [États-Unis] ; J. W. Langston [États-Unis] ; J. R. Barrio [États-Unis]Novel observations with FDOPA-PET imaging after early nigrostriatal damage
002957 Massimo Pandolfo [Canada]Molecular basis of friedreich ataxia
002965 Arthur S. Walters [États-Unis] ; Juliane Winkelmann [Allemagne] ; Claudia Trenkwalder [Allemagne] ; June M. Fry [États-Unis] ; Vandana Kataria [États-Unis] ; Mary Wagner [États-Unis] ; Rakesh Sharma [États-Unis] ; Wayne Hening [États-Unis] ; LIREN LI [États-Unis]Long-term follow-up on restless legs syndrome patients treated with opioids
002966 Fabrizio Stocchi [Italie] ; Laura Vacca [Italie] ; Alfredo Berardelli [Italie] ; Francesca De Pandis [Italie] ; Stefano Ruggieri [Italie]Long-duration effect and the postsynaptic compartment : Study using a dopamine agonist with a short half-life
002985 Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis]History of movement disorders as a neurological specialty: Part 14 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000
002996 Zbigniew K. Wszolek [États-Unis] ; Randy H. Kardon [États-Unis] ; Erik Ch. Wolters [Pays-Bas] ; Ronald F. Pfeiffer [États-Unis]Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): PPND family. A longitudinal videotape demonstration
002999 J. H. Friedman [États-Unis] ; H. Friedman [États-Unis]Fatigue in Parkinson's disease: A nine-year follow-up
002A12 Birgit Högl [Allemagne] ; Cecilia Peralta [Argentine] ; Thomas C. Wetter [Allemagne] ; Oscar Gershanik [Argentine] ; Claudia Trenkwalder [Allemagne]Effect of sleep deprivation on motor performance in patients with Parkinson's Disease
002A15 Jorg Müller [Autriche] ; Georg Ebersbach [Autriche] ; Jorg Wissel [Autriche] ; Werner Poewe [Autriche]Dynamic balance function in phasic cervical dystonia following Botulinum toxin therapy
002A24 G. Wihl [Allemagne] ; J. Volkmann [Allemagne] ; N. Allert [Allemagne] ; R. Lehrke [Allemagne] ; V. Sturm [Allemagne] ; H.-J. Freund [Allemagne]Deep brain stimulation of the internal pallidum did not improve chorea in a patient with neuro-acanthocytosis
002A87 H. T. S. Benamer [Royaume-Uni] ; A. J. C. Russell [Royaume-Uni] ; D. M. Hadley [Royaume-Uni] ; D. G. Grosset [Royaume-Uni]Unilateral arm tremor as the sole feature of ischemic stroke : A 5-year follow up
002A92 R. A. Hauser [États-Unis] ; W. C. Koller [États-Unis] ; J. P. Hubble [États-Unis] ; T. Malapira [États-Unis] ; K. Busenbark [États-Unis] ; C. W. Olanow [États-Unis]Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's Disease
002A99 Evelyn Jaros [Royaume-Uni] ; David J. Burn [Royaume-Uni]The pathogenesis of multiple system atrophy : Past, present, and future
002B04 L. M. Shulman [États-Unis] ; A. Minagar [États-Unis] ; W. J. Weiner [États-Unis]The effect of pregnancy in Parkinson's disease
002B07 S. Frucht [États-Unis] ; S. Fahn [États-Unis]The clinical spectrum of posthypoxic myoclonus
002B27 E. H. Aylward [États-Unis] ; A.-M. Codori [États-Unis] ; A. Rosenblatt [États-Unis] ; M. Sherr [États-Unis] ; J. Brandt [États-Unis] ; O. C. Stine [États-Unis] ; P. E. Barta [États-Unis] ; G. D. Pearlson [États-Unis] ; C. A. Ross [États-Unis]Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease
002B40 C. G. Goetz [États-Unis] ; T. Q. Vu ; P. M. Carvey ; S. LeurgansPosthypoxic myoclonus in the rat : Natural history, stability, and serotonergic influences
002B43 Svenja Happe [Allemagne] ; Peter Lüdemann [Allemagne] ; E. Bernd Ringelstein [Allemagne]Persistence of rhythmic movement disorder beyond childhood: A videotape demonstration
002B47 A. Brashear [États-Unis] ; K. Bergan [États-Unis] ; J. Wojcieszek [États-Unis] ; E. R. Siemers [États-Unis] ; W. Ambrosius [États-Unis]Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A
002B53 Laurent Vercueil [France] ; Abdallah Hammouti [France] ; Marcellin L. Andriantseheno [France] ; Michel Mohr [France] ; Christine Tranchant [France] ; Pierre Maquet [Belgique] ; Christian Marescaux [France] ; Francois Sellal [France]Pallido-luysio-nigral atrophy revealed by rapidly progressive hemidystonia : A clinical, radiologic, functional, and neuropathologic study
002B58 Nagako Murase [Japon] ; Ryuji Kaji [Japon] ; Takashi Sakamoto [Japon] ; Hineki Shimazu [Japon] ; Shinnichi Matumoto [Japon] ; Nobuo Kohar [Japon] ; Hiroshi Shibasaki [Japon] ; Jun Kimura [États-Unis]Nicotine-sensitive writer's cramp
002B73 C. F. L. Souza-Lima [Brésil] ; H. Ballalai Ferraz [Brésil] ; C. A. Braz [Brésil] ; A. M. Araüjo [Brésil] ; G. Mastrocola Manzano [Brésil]Marked improvement in a stiff-limb patient treated with intravenous immunoglobulin
002B75 Lucia Angelini [Italie] ; Nardo Nardocci [Italie] ; Margherita Estienne [Italie] ; Chiara Conti [Italie] ; Ivano Dones [Italie] ; Giovanni Broggi [Italie]Life-threatening dystonia-dyskinesias in a child : Successful treatment with bilateral pallidal stimulation
002B98 P. Hagell [Suède] ; L. Crabb [Royaume-Uni] ; O. Pogarell [Allemagne] ; A. Schrag [Royaume-Uni] ; H. Widner [Suède] ; D. J. Brooks [Royaume-Uni] ; W. H. Oertel [Allemagne] ; N. P. Quinn [Royaume-Uni] ; O. Lindvall [Suède]Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease
002C09 Rebecca J. Carter [Royaume-Uni] ; Mark J. Hunt [Royaume-Uni] ; A. Jennifer Morton [Royaume-Uni]Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene
002C21 C. G. Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; L. M. Blasucci [États-Unis]Differential progression of motor impairment in levodopa-treated Parkinson's Disease
002C28 Harvey S. Singer [États-Unis]Current issues in tourette syndrome
002C48 M. I. Hariz [Suède] ; F. Johansson [Suède] ; P. Shamsgovara [Suède] ; E. Johansson [Suède] ; G.-M. Hariz [Suède] ; M. Fagerlund [Suède]Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition : Persistent improvement in mobility but increased dependency : A case study
002C51 A. Schrag [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Benign hereditary chorea : Entity or syndrome?
002C59 F. Stocchi [Italie] ; D. Badiali [Italie] ; L. Vacca [Italie] ; L. D'Alba [Italie] ; F. Bracci [Italie] ; S. Ruggieri [Italie] ; M. Torti [Italie] ; A. Berardelli [Italie] ; E. Corazziari [Italie]Anorectal function in multiple system atrophy and Parkinson's disease
002C67 V. G. H. Evidente [États-Unis, Philippines] ; C. H. Adler [États-Unis] ; J. N. Caviness [États-Unis] ; J. G. Hentz [États-Unis] ; K. Gwinn-Hardy [États-Unis]Amantadine is beneficial in restless legs syndrome
002C93 M. Merello [Argentine] ; M. I. Nouzeilles [Argentine] ; G. Kuzis [Argentine] ; A. Cammarota [Argentine] ; L. Sabe [Argentine] ; O. Betti [Argentine] ; S. Starkstein [Argentine] ; R. Leiguarda [Argentine]Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum : A prospective randomized comparison
002D21 W. Pirker [Autriche] ; C. Baumgartner [Autriche] ; S. Brugger [Autriche] ; D. Prayer [Autriche] ; S. Kandlhofer [Autriche] ; S. Asenbaum [Autriche] ; L. Deecke [Autriche] ; T. Brücke [Autriche] ; K. W. Lange [Allemagne]Severe akinetic syndrome resulting from a bilateral basal ganglia lesion following bone marrow transplantation
002D38 G. Linazasoro [Espagne] ; J. Suarez [Espagne] ; C. Duran [Espagne] ; A. Berenguer [Espagne]Progressive, asymmetric cortical visual disturbances and movement disorders in two patients
002D39 G. K. Wenning [Autriche] ; G. Ebersbach [Autriche] ; M. Verny [France] ; K. Ray Chaudhuri [Royaume-Uni] ; K. Jellinger [Autriche] ; A. Mckee [États-Unis] ; Werner Poewe [États-Unis] ; I. Litvan [États-Unis]Progression of falls in postmortem-confirmed Parkinsonian disorders
002D50 F. Cardoso [Brésil] ; A. P. Vargas [Brésil] ; L. D. Oliveira [Brésil] ; A. A. Guerra [Brésil] ; S. V. Amaral [Brésil]Persistent Sydenham's chorea
002D57 M. T. Pellecchia [Italie] ; T. Cuomo [Italie] ; S. Striano [Italie] ; A. Filla [Italie] ; P. Barone [Italie]Paroxysmal dystonia in Behçet's disease
002D62 I. Sibon [France] ; Y. Rajabally [France] ; F. Tison [France]Parkinsonism as a result of a giant aneurysm
002D63 N. A. Leopold [États-Unis] ; W. Bara-Jimenez [États-Unis] ; M. Hallett [États-Unis]Parkinsonism after a wasp sting
002D75 T. Yanagisawa [Japon] ; H. Sugihara [Japon] ; K. Shibahara [Japon] ; T. Kamo [Japon] ; K. Fujisawa [Japon] ; M. Murayama [Japon]Natural course of combined limb and palatal tremor caused by cerebellar-brain stem infarction
002D81 Joseph Jankovic [États-Unis] ; L. Ben-Arie [États-Unis] ; K. Schwartz [États-Unis] ; KIM CHEN [États-Unis] ; M. Khan [États-Unis] ; E. C. Lai [États-Unis] ; J. K. Krauss [États-Unis] ; R. Grossman [États-Unis]Movement and reaction times and fine coordination tasks following pallidotomy
002E19 K. A. Reardon [Australie] ; M. Shiff [Australie] ; P. A. Kempster [Australie]Evolution of motor fluctuations in Parkinson's disease : A longitudinal study over 6 years
002E21 A. S.-I. Pakiam [Canada] ; A. E. Lang [Canada]Essential palatal tremor : Evidence of heterogeneity based on clinical features and response to sumatriptan
002E84 J. M. Graham [Royaume-Uni] ; BSC [Royaume-Uni] ; H. J. Sagar [Royaume-Uni] ; DM [Royaume-Uni]A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease : Identification of three distinct subtypes
002E91 A. Schrag [Royaume-Uni] ; Y. Ben-Shlomo [Royaume-Uni] ; R. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; N. Quinn [Royaume-Uni]Young-onset Parkinson's disease revisited : Clinical features, natural history, and mortality
002E96 F. Ovsiew [États-Unis] ; K. J. Meador [États-Unis] ; K. Sethi [États-Unis]Verapamil for severe hyperkinetic movement disorders
002F00 S. Siesling [Pays-Bas] ; J. P. P. Van Vugt [Pays-Bas] ; K. A. H. Zwinderman [Pays-Bas] ; K. Kieburtz [États-Unis] ; R. A. C. Roos [Pays-Bas]Unified Huntington's disease rating scale : A follow up
002F05 R. Lindeboom [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; M. Aramideh [Pays-Bas] ; H. D. Speelman [Pays-Bas] ; R. J. De Haan [Pays-Bas]Treatment of cervical dystonia : A comparison of measures for outcome assessment
002F54 S. M. Mirsattari [Canada] ; C. Power [Canada] ; A. Nath [Canada, États-Unis]Parkinsonism with HIV infection
002F59 W. G. Ondo [États-Unis] ; J. M. Desaloms [États-Unis] ; Joseph Jankovic [États-Unis] ; R. G. Grossman [États-Unis]Pallidotomy for generalized dystonia
002F94 K. E. Lyons [États-Unis] ; R. Pahwa [États-Unis] ; K. L. Busenbark [États-Unis] ; A. I. Tröster [États-Unis] ; S. Wilkinson [États-Unis] ; W. C. Koller [États-Unis]Improvements in daily functioning after deep brain stimulation of the thalamus for intractable tremor
003013 J. A. Loeb [États-Unis]Functional improvement in a patient with cerebral calcinosis using a bisphosphonate
003029 C. M. Gudex [Danemark] ; M. R. Hawthorne [Royaume-Uni] ; A. G. Butler [Royaume-Uni] ; P. Duffey [Royaume-Uni]Effect of dystonia and botulinum toxin treatment on health-related quality of life
003041 G. Deuschl [Allemagne] ; B. Köster [Allemagne] ; C. H. Lücking [Allemagne] ; C. Scheidt [Allemagne]Diagnostic and pathophysiological aspects of psychogenic tremors
003125 P. Lewitt [États-Unis] ; D. Oakes [États-Unis] ; L. Cui [États-Unis]The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α-tocopherol
003162 L. Derex [France] ; P. Trouillas [France]Reversible parkinsonism, hypophosphoremia, and hypocalcemia under vitamin D therapy
003184 P. K. Morrish [Royaume-Uni]Parkinson's disease is not a long-latency illness
003188 T. Stojkovic [France] ; L. Defebvre [France] ; X. Quilliet [France] ; E. Eveno [France] ; A. Sarasin [France] ; M. Mezzina [France] ; A. Destee [France]Neurological manifestations in two related xeroderma pigmentosum group D patients: Complications of the late-onset type of the juvenile form
003213 J. K. Krauss [États-Unis] ; R. G. Grossman [États-Unis] ; Joseph Jankovic [États-Unis]Improvement of Parkinsonian signs after vascular lesions of the basal ganglia circuitry
003288 J. Maher [Canada] ; S. Choudhri [Canada] ; W. Halliday [Canada] ; C. Power [Canada] ; A. Nath [Canada]AIDS dementia complex with generalized myoclonus
003313 E. S. Molho [États-Unis] ; S. A. Factor [États-Unis] ; G. D. Podskalny ; D. Brown [États-Unis]The effect of dancing on dystonia
003390 R. A. C. Roos [Pays-Bas] ; J. C. F. Jongen [Pays-Bas] ; E. A. Van Der VeldeClinical course of patients with idiopathic Parkinson's disease
003394 M. A. Nance [États-Unis] ; G. Sanders [États-Unis]Characteristics of individuals with Huntington disease long-term care
003406 S. Jain [Inde] ; S. K. Tamer [Inde] ; S. Hiran [Inde]Beneficial effect of alcohol in hereditary cerebellar ataxia with myoclonus (progressive myoclonic ataxia) : Report of two siblings
003496 A. Feigin [États-Unis] ; K. Kieburtz ; K. Bordwell ; P. Como ; K. Steinberg ; J. Sotack ; C. Zimmerman ; C. Hickey ; C. Orme ; I. ShoulsonFunctional decline in Huntington's disease
003500 D. W. Claypool [États-Unis] ; D. D. Duane ; D. M. Ilstrup [États-Unis] ; L. J. Melton [États-Unis]Epidemiology an outcome of cervical dystonia (spasmodic torticollis) in Rochester, Minnesota
003728 L. Edwards [États-Unis] ; E. M. M. Quigley ; R. Hofman [États-Unis] ; R. F. Pfeiffer [États-Unis]Gastrointestinal symptoms in parkinson disease : 18-month follow-up study

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024